Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Phibro Animal Health (PAHC)
NASDAQ:PAHC
RESEARCH TOOLSreports
Phibro Animal Health (PAHC) Stock Price & Analysis
59 Followers
PAHC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$9.15 - $18.57
Previous Close$17.04
Volume99.47K
Average Volume (3M)139.80K
Market Cap
$690.18M
Enterprise Value$1.07B
Total Cash (Recent Filing)$92.49M
Total Debt (Recent Filing)$474.90M
Price to Earnings (P/E)52.4
Beta0.84
Next Earnings
Aug 28, 2024EPS Estimate
$0.33Last Dividend Ex-Date
Jun 05, 2024Dividend Yield2.86%
Share Statistics
EPS (TTM)0.32
Shares Outstanding40,503,608
10 Day Avg. Volume123,020
30 Day Avg. Volume139,800
Standard Deviation0.11
R-Squared0.08
Alpha-0.00723
Financial Highlights & Ratios
Price to Book (P/B)4.33
Price to Sales (P/S)0.37
Price to Cash Flow (P/CF)5.70
P/FCF Ratio7.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.09
Enterprise Value/Gross Profit3.60
Enterprise Value/Ebitda11.58
Forecast
1Y Price Target
$16.00Price Target Upside-4.19% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering2
Phibro Animal Health News
PremiumCompany Announcements
Phibro Animal Health Expands Portfolio with Zoetis Acquisition
Bulls Say, Bears Say
Bulls Say
AcquisitionsThe pending agreement to acquire Zoetis’s MFA franchise is seen as offering meaningful earnings per share accretion and expanding PAHC’s offerings into new markets.
Product InnovationVaccines posted another solid quarter with a 26% growth, driven by PAHC’s new poultry product offerings in Latin America.
Revenue GrowthAnimal Health segment revenues of $181.3 million grew by 10% year-over-year, driven by strength in MFAs and other products, reflecting increased global demand.
Bears Say
EarningsNutritional Specialties fell 11% Y/Y mostly due to lower demand for microbial and dairy.
Financial PerformanceNutritional Specialties fell short of the forecast, declining -11% on lower sales into the dairy market.
RevenuePerformance Products sales of $17.7mn missed the $19.6mn estimate.
---
Ownership Overview
9.18%
Insiders
26.25% Mutual Funds
25.68% Other Institutional Investors
38.88% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PAHC FAQ
What was Phibro Animal Health’s price range in the past 12 months?
Phibro Animal Health lowest stock price was $9.14 and its highest was $18.57 in the past 12 months.
What is Phibro Animal Health’s market cap?
Currently, no data Available
When is Phibro Animal Health’s upcoming earnings report date?
Phibro Animal Health’s upcoming earnings report date is Aug 28, 2024 which is in 56 days.
How were Phibro Animal Health’s earnings last quarter?
Phibro Animal Health released its earnings results on May 08, 2024. The company reported $0.31 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.02.
Is Phibro Animal Health overvalued?
According to Wall Street analysts Phibro Animal Health’s price is currently Overvalued.
Does Phibro Animal Health pay dividends?
Phibro Animal Health pays a Quarterly dividend of $0.12 which represents an annual dividend yield of 2.86%. See more information on Phibro Animal Health dividends here
What is Phibro Animal Health’s EPS estimate?
Phibro Animal Health’s EPS estimate is $0.33.
How many shares outstanding does Phibro Animal Health have?
Phibro Animal Health has 20,337,574 shares outstanding.
What happened to Phibro Animal Health’s price movement after its last earnings report?
Phibro Animal Health reported an EPS of $0.31 in its last earnings report, beating expectations of $0.29. Following the earnings report the stock price went up 3.048%.
Which hedge fund is a major shareholder of Phibro Animal Health?
Among the largest hedge funds holding Phibro Animal Health’s share is Brandes Investment Partners LP. It holds Phibro Animal Health’s shares valued at 31M.
---
Phibro Animal Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$16.00 (-4.19% Downside)
$16.00 (-4.19% Downside)
Blogger Sentiment
Bullish
PAHC Sentiment 66%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 210.9K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
28.91%
12-Months-Change
Fundamentals
Return on Equity
4.85%
Trailing 12-Months
Asset Growth
1.41%
Trailing 12-Months
Company Description
Phibro Animal Health
Phibro Animal Health Corp. engages in the manufacture of animal health and mineral nutrition products. It operates through the following business segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops, manufactures, and markets antibacterial, nutritional specialty products, and vaccines. The Mineral Nutrition segment comprises of the formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment offers production of specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.
---
PAHC Company Deck
---
PAHC Earnings Call
Q3 2024
0:00 / 0:00
---
PAHC Stock 12 Month Forecast
Average Price Target
$16.00
▼(-4.19% Downside)
Technical Analysis
Best Analysts Covering PAHC
1 Year
1 Year Success Rate
6/9 ratings generated profit
1 Year Average Return
-7.69%
reiterated a sell rating 2 months ago
Copying Balaji Prasad's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of -7.69% per trade.
---